Gene Therapy Clinical Trials
Our site has years of experience with over 300 patients with Inherited Retinal Diseases (IRD) in our clinic. NEED TEXT
Clinical Trial Site Parameters
- Experienced Retina Surgeons
- Site Specific Research Coordinators
- Ophthalmic Genetic Counselor
- Specialized Lab Space
- Microscope
- What else?
Ascent Gene Therapy Clinical Trial
This clinical trial evaluates a gene therapy product, RGX-314, for patients with choroidal neovascularization (CNV), a form of wet age-related macular degeneration (AMD). The purpose of this study is to evaluate the safety and efficacy of a single RGX-314 subretinal injection in participants with AMD compared to repeated intravitreal (ITV) injections.